MSF Science Portal

MSF Scientific Days 2025

MSF Scientific Day is on 22 May 2025. This annual conference highlights medical research from fragile and conflict-affected settings, bringing together researchers, innovators, and advocates.

This year's keynote speaker is Dr. Sania Nishtar, Chief Executive Officer of Gavi, the Vaccine Alliance. This year's sessions are:

London Calling: operationalising research from findings to frontlines
Rethinking approaches to malnutrition as cases rise and budgets shrink
Melioidosis, microbes, and mosquitoes: pushing boundaries for the most neglected and most vulnerable
Vaccination, a humanitarian lifeline under threat: Where do we focus? How do we resist?

Learn more and register

Deadline Extended: MSF Scientific Days LatAm 2025

Deadline extended! Submit your abstract for MSF Scientific Days Latin America 2025 by Monday, May 26

The categories for submission are research, innovation, and storytelling. The theme this year is Breaking Barriers: Ensuring Sexual and Reproductive Health for All in Humanitarian Crises.

This conference is a space designed for health professionals around the world to meet to discuss and challenge research within the humanitarian sector in Latin America.

Read the abstract guidelines

endTB: finding shorter, less toxic, and more effective treatments for MDR-TB

The endTB project aims to find shorter, less toxic and more effective treatments for ‘multidrug-resistant TB’ (MDR-TB) through: 1) access to new drugs, 2) two clinical trials, and 3) advocacy at national and global levels.

The groundbreaking endTB clinical trial results were just published, where a personalized medicine approach highlights the benefits of a new shorter treatment strategy for extensively drug-resistant tuberculosis.

Read the new publication and over 40 research resources, publications, and protocol documents from the endTB project.

View the collection

MSF Science Portal

MSF Scientific Days 2025

Deadline Extended: MSF Scientific Days LatAm 2025

endTB: finding shorter, less toxic, and more effective treatments for MDR-TB

Find MSF Ethics Review Board documents here, and other MSF research and publication guidance documents here.

Featured Content

Editor’s Picks

Environmental changes in South Sudan are changing the fabric of people’s lives and steering humanitarian operations

Assessing post-abortion care using the WHO quality of care framework for maternal and newborn health: a cross-sectional study in two African hospitals in humanitarian settings

The role of humanitarian actors in global governance for AMR

Prevalence of active HCV infection and associated risk factors among members of Forcibly Displaced Myanmar National (FDMN) Population residing in camps, Cox’s Bazar, Bangladesh

High caseload of Scabies amongst Rohingya refugees in Cox’s Bazar, Bangladesh: a retrospective analysis of the epidemiological and clinical characteristics of cases, July 2022 to November 2023

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis

Scaling up cervical cancer screening in Southern Malawi: Screening models for difficult-to-reach populations

Transforming MSF’s approach to community-led initiatives

Joint brief: The Lancet Countdown on Health and Climate Change & Médecins Sans Frontières

Environmental changes in South Sudan are changing the fabric of people’s lives and steering humanitarian operations

Assessing post-abortion care using the WHO quality of care framework for maternal and newborn health: a cross-sectional study in two African hospitals in humanitarian settings

The role of humanitarian actors in global governance for AMR

Prevalence of active HCV infection and associated risk factors among members of Forcibly Displaced Myanmar National (FDMN) Population residing in camps, Cox’s Bazar, Bangladesh

High caseload of Scabies amongst Rohingya refugees in Cox’s Bazar, Bangladesh: a retrospective analysis of the epidemiological and clinical characteristics of cases, July 2022 to November 2023

24-week, all-oral regimens for pulmonary rifampicin-resistant tuberculosis in TB-PRACTECAL trial sites: an economic evaluation

Oral regimens for rifampin-resistant, fluoroquinolone-susceptible tuberculosis

Scaling up cervical cancer screening in Southern Malawi: Screening models for difficult-to-reach populations

Transforming MSF’s approach to community-led initiatives

Joint brief: The Lancet Countdown on Health and Climate Change & Médecins Sans Frontières

Environmental changes in South Sudan are changing the fabric of people’s lives and steering humanitarian operations

Assessing post-abortion care using the WHO quality of care framework for maternal and newborn health: a cross-sectional study in two African hospitals in humanitarian settings

The role of humanitarian actors in global governance for AMR

Prevalence of active HCV infection and associated risk factors among members of Forcibly Displaced Myanmar National (FDMN) Population residing in camps, Cox’s Bazar, Bangladesh

Newest Content